There are new questions about who — in the rubber industry — is affected by bladder cancer. A former Sumitomo Rubber employee ...

WHEN you notice something out of the ordinary down below, it’s only natural to worry. While some changes are normal, others can be a sign of something more serious – and even warrant pretty ...

Bladder cancer is a common cancer and one of the most costly to treat, yet there has been little change in the standard of care in 40 years. This panel will focus on the unmet needs in bladder ...

Merck, a leading science and technology company, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 American Society of Clinical Oncology (ASCO) Annual ...

EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the presentation of new oncology data across more than 12 tumor types at the 2025 ...

When prostate cancer is advanced, meaning it has grown larger or has metastasized, it can cause other problems including erectile dysfunction; weakness or numbness in the legs; loss of bladder or ...

More than 70% of bladder cancer patients are diagnosed with NMIBC ... Immune-Mediated Dermatology Reactions IMFINZI and IMJUDO can cause immune-mediated rash or dermatitis. Exfoliative dermatitis, ...

MAY IS BLADDER CANCER AWARENESS MONTH A TIME TO SHINE A LIGHT ON THIS OFTEN OVERLOOKED DISEASE THAT AFFECTS THOUSANDS OF PEOPLE EACH YEAR. JOINING ME NOW IS DOCTOR MURAD ABELARDO, A UROLOGIST WITH ...

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery and other types of more invasive treatment to cure their disease.

“Today’s approval for Imfinzi represents a paradigm shift, bringing the first perioperative immunotherapy to patients in the US with muscle-invasive bladder cancer and addressing a significant ...

Pfizer’s investigational anti-PD-1 antibody significantly reduced disease events in patients with high-risk non-muscle-invasive bladder cancer, according to results ... Common immune-mediated adverse ...

Meri-Margaret Deoudes, CEO of the Bladder Cancer Advocacy Network ... increased alkaline phosphate, rash, pyrexia, diarrhea, vomiting and abdominal pain. In patients with MIBC in the neoadjuvant ...